We are live on ! Find out more
USNA icon

Usana Health Sciences

145 hedge funds and large institutions have $582M invested in Usana Health Sciences in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

38% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 40

12% more funds holding

Funds holding: 129145 (+16)

7% more capital invested

Capital invested by funds: $541M → $582M (+$40.3M)

3.85% more ownership

Funds ownership: 51.63%55.48% (+3.9%)

Holders
145
Holders Change
+16
Holders Change %
+12.4%
% of All Funds
4.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
55
Reduced
40
Closed
10
Calls
Puts
Net Calls
Net Calls Change

USNA Hedge Fund Activity: Q1 2014 in Review

145 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2014, worth a combined $582M — up 7.4% from $541M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new USNA positions and 10 closed out — a net gain of 17 holders — while 55 added to existing stakes and 40 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $5.12M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $3.54M sold.

  • 145 institutional investors held Usana Health Sciences (USNA) as of Q1 2014, up from 129 in Q4 2013.
  • Funds reported $582M of Usana Health Sciences stock for Q1 2014, up 7.4% quarter-over-quarter.
  • 27 funds opened new Usana Health Sciences positions in Q1 2014 and 10 closed out, a net change of +17 holders.
  • The largest Usana Health Sciences buyer in Q1 2014 was Renaissance Technologies, an estimated $5.12M added.
  • The largest Usana Health Sciences seller in Q1 2014 was Oxford Asset Management, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2014.